Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more
Dezhan HealthCare Co Ltd (000813) - Total Assets
Latest total assets as of September 2025: CN¥5.23 Billion CNY
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) holds total assets worth CN¥5.23 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dezhan HealthCare Co Ltd - Total Assets Trend (1995–2024)
This chart illustrates how Dezhan HealthCare Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dezhan HealthCare Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Dezhan HealthCare Co Ltd's total assets of CN¥5.23 Billion consist of 63.0% current assets and 37.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 47.6% |
| Accounts Receivable | CN¥603.76 Million | 11.4% |
| Inventory | CN¥197.87 Million | 3.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥176.37 Million | 3.3% |
| Goodwill | CN¥289.71 Million | 5.5% |
Asset Composition Trend (1995–2024)
This chart illustrates how Dezhan HealthCare Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dezhan HealthCare Co Ltd's current assets represent 63.0% of total assets in 2024, a decrease from 69.4% in 1995.
- Cash Position: Cash and equivalents constituted 47.6% of total assets in 2024, up from 7.4% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is accounts receivable at 11.4% of total assets.
Dezhan HealthCare Co Ltd Competitors by Total Assets
Key competitors of Dezhan HealthCare Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Dezhan HealthCare Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Dezhan HealthCare Co Ltd generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Dezhan HealthCare Co Ltd is currently not profitable relative to its asset base.
Dezhan HealthCare Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 28.79 | 37.50 | 11.62 |
| Quick Ratio | 27.01 | 35.20 | 10.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.08 Billion | CN¥ 3.34 Billion | CN¥ 4.39 Billion |
Dezhan HealthCare Co Ltd - Advanced Valuation Insights
This section examines the relationship between Dezhan HealthCare Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.53 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | CN¥5.32 Billion |
| Market Capitalization | $614.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dezhan HealthCare Co Ltd's assets below their book value (0.12 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Dezhan HealthCare Co Ltd's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Dezhan HealthCare Co Ltd (1995–2024)
The table below shows the annual total assets of Dezhan HealthCare Co Ltd from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.32 Billion | -1.09% |
| 2023-12-31 | CN¥5.38 Billion | -5.21% |
| 2022-12-31 | CN¥5.67 Billion | -1.79% |
| 2021-12-31 | CN¥5.78 Billion | -9.71% |
| 2020-12-31 | CN¥6.40 Billion | +7.96% |
| 2019-12-31 | CN¥5.93 Billion | +0.10% |
| 2018-12-31 | CN¥5.92 Billion | +15.23% |
| 2017-12-31 | CN¥5.14 Billion | +30.86% |
| 2016-12-31 | CN¥3.93 Billion | +99.11% |
| 2015-12-31 | CN¥1.97 Billion | -2.93% |
| 2014-12-31 | CN¥2.03 Billion | +6.90% |
| 2013-12-31 | CN¥1.90 Billion | +219.56% |
| 2012-12-31 | CN¥594.73 Million | -11.08% |
| 2011-12-31 | CN¥668.82 Million | +4.62% |
| 2010-12-31 | CN¥639.31 Million | +23.83% |
| 2009-12-31 | CN¥516.28 Million | -4.70% |
| 2008-12-31 | CN¥541.74 Million | -8.33% |
| 2007-12-31 | CN¥590.94 Million | +2.23% |
| 2006-12-31 | CN¥578.04 Million | -3.23% |
| 2005-12-31 | CN¥597.31 Million | -17.93% |
| 2004-12-31 | CN¥727.81 Million | -31.04% |
| 2003-12-31 | CN¥1.06 Billion | -13.78% |
| 2002-12-31 | CN¥1.22 Billion | +0.58% |
| 2001-12-31 | CN¥1.22 Billion | -10.33% |
| 2000-12-31 | CN¥1.36 Billion | +18.47% |
| 1999-12-31 | CN¥1.15 Billion | +1.55% |
| 1998-12-31 | CN¥1.13 Billion | +3.77% |
| 1997-12-31 | CN¥1.09 Billion | +13.67% |
| 1996-12-31 | CN¥956.52 Million | +1.19% |
| 1995-12-31 | CN¥945.30 Million | -- |